Can a new sedative make bronchoscopy safer and smoother?

NCT ID NCT07744061

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether ciprofol, a newer sedative, provides better and safer sedation than the standard drug propofol for people undergoing bronchoscopy, a procedure to examine the airways. Both are given with a low dose of sufentanil for pain relief. The study involves 100 adults aged 35 to 65 with mild or no systemic disease, randomly assigned to receive one of the two sedatives. Researchers will measure the total sedative dose needed, side effects like breathing or blood pressure changes, and how quickly patients wake up and recover.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ciprofol (an intravenous sedative) compared with propofol, both combined with low-dose sufentanil
What this could lead to
If ciprofol works better, it could offer a safer, more comfortable sedation option for bronchoscopy, with fewer breathing or blood pressure problems.
What could go wrong
This is a small, early-stage comparison. Ciprofol may not prove superior to propofol, and any sedative carries risks like breathing suppression or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wenzhou Central Hospital

    Wenzhou, Zhejiang, 325000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.